Piramal Enterprises secured the approval of the National Company Law Tribunal (NCLT) for the demerger of its pharmaceutical business and the simplification of its corporate structure, the company said in a regulatory filing. The record date for the demerger of the pharma business from the finance business has been set as September 1 and stock traded ex-demerger on Tuesday as the markets will remain shut on Wednesday on the account Ganesh Chaturthi.
Kaynes shares plunge 43% from October peak. Is a tactical rebound on the cards or more pain ahead?
Kaynes has plunged 43.5% from its October peak, with Friday’s 12.5% drop marking the steepest single-day decline. Momentum indicators remain bearish, signaling a risk of
December 7, 2025